3-iodobenzylguanidine has been researched along with phenylalanine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beierwaltes, W; Froelich, J; Gonin, J; Macfarlane, D; Mangner, T; Shapiro, B; Wieland, D | 1 |
Arai, K; Asahina, M; Funayama, M; Hattori, N; Hattori, T; Kanai, K; Kuwabara, S; Kuwabara, Y; Sekiguchi, Y; Tomiyama, H; Uchiyama, T | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and phenylalanine
Article | Year |
---|---|
Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
Topics: 3-Iodobenzylguanidine; Adult; Animals; Carcinoid Tumor; Dogs; Enzyme Inhibitors; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Mast-Cell Sarcoma; Mice; Middle Aged; Neoplasms, Experimental; Phenylalanine; Predictive Value of Tests; Radionuclide Imaging; Rats; Sensitivity and Specificity; Serotonin; Somatostatin; Tissue Distribution; Tryptophan Hydroxylase | 1996 |
Preserved cardiac (123)I-MIBG uptake and lack of severe autonomic dysfunction in a PARK9 patient.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Heart; Humans; Leucine; Male; Myocardium; Parkinsonian Disorders; Phenylalanine; Proton-Translocating ATPases; Radionuclide Imaging; Young Adult | 2009 |